Cancer News and Research

Latest Cancer News and Research

Developing biomaterials for soft tissue reconstruction

Explore how biomaterials and additive manufacturing support medical device development for soft tissue reconstruction.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 13 Oct 2026

Childhood leukemia treatment causes rapid, lasting challenges for patient families

New research in the October 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that families of children receiving treatment for B-cell acute lymphoblastic leukemia (B-ALL) experience substantial and lasting challenges beginning early after diagnosis, according to a new multicenter study embedded in a Children's Oncology Group (COG) trial.

13 Oct 2026

Women with polyendocrine metabolic ovarian syndrome more likely to have Alzheimer's and dementia

Alzheimer's disease and dementia may be more common in women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), according to a review of existing evidence published in the Journal of the Endocrine Society.

13 Oct 2026

Replacement chemical for harmful phthalates may restrict fetal growth

A chemical used to make plastic more flexible, once introduced as a safer substitute for older additives now known to be harmful, may itself also be harmful, slowing babies' growth in the womb, a new study shows.

13 Oct 2026

Single-cell analysis reveals how pancreatic cancer evades treatment

An analysis of nearly half a million cells from dozens of patients' tumors reveals how cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment for one of the deadliest forms of cancer.

13 Oct 2026

Undecimal Bio launches with $18 million oversubscribed seed financing to address ‘liver trap’ in siRNA therapeutic delivery

Undecimal Bio, a platform biotechnology company advancing targeted delivery of siRNA therapeutics, today announced an oversubscribed $18 million USD seed financing.

From UndecimalBio 13 Oct 2026

Study identifies Piezo channels as targets for orthodontic care

A new review in Genes & Diseases highlights Piezo channels as important biological links between mechanical forces and the cellular processes that shape the face, move teeth and influence oral health.

12 Oct 2026

Long non-coding RNAs offer new pathways to overcome cancer treatment resistance

Scientists are highlighting long non-coding RNAs (lncRNAs) as promising targets in the effort to overcome one of cancer treatment's most persistent challenges: therapeutic resistance.

12 Oct 2026

RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers

A new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially important biomarker and therapeutic target across gastrointestinal cancers.

12 Oct 2026

Review highlights EP4 receptor as target for inflammatory diseases

A review published in Genes & Diseases highlights the prostaglandin E2 receptor subtype 4 (EP4) as an important regulator of inflammation and a promising therapeutic target for a wide range of inflammatory and inflammation-related diseases.

12 Oct 2026

Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer

A deeper understanding of mitochondrial function could create new opportunities for treating triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of breast cancer.

12 Oct 2026

Targeting lipophagy could help treat metabolic and oxidative stress-related diseases

A review published in Genes & Diseases highlights lipophagy, the cellular process that selectively breaks down lipid droplets, as a potentially important therapeutic target for conditions driven by disrupted lipid metabolism and oxidative stress.

12 Oct 2026

New review highlights expanding potential of therapeutic DNA vaccines

A new review published in Genes & Diseases highlights the expanding potential of DNA-based vaccines as a flexible platform for preventing infectious diseases, treating cancer and strengthening preparedness for future disease outbreaks.

12 Oct 2026

Buck Institute and Georgetown lead effort mapping harmful protein changes before disease begins

A research "super team" co-led by theBuck Institute for Research on Aging and Georgetown University has received an award of up to $51.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to predict how disease-causing proteins misfold before irreversible damage occurs and use those predictions to develop novel diagnostics and treatments.

12 Oct 2026

Oregon's licensed psilocybin centers prioritize safety but remain highly expensive

A new study has found that Oregon's licensed psilocybin centers largely follow recommended safety guidelines, offering reassurance about how the first regulated psilocybin programs in the U.S. function in practice - though the cost of treatment may keep it out of reach for many.

12 Oct 2026

Magnetically guided millirobots deliver targeted drugs to beating hearts

Johns Hopkins University engineers have created robots the size of a pencil tip intended to travel through the body to deliver medicine to infections inside a beating heart.

12 Oct 2026

Study maps psychological networks linked to suicidal ideation

Suicidal ideation can involve interconnected psychological processes. Researchers from Pusan National University examined 2,018 adults across Italy, Korea, the UK, and the US to map psychosocial networks related to suicidal ideation.

12 Oct 2026

Most online breast cancer diet advice lacks strong evidence

Over 87% of online breast cancer nutrition claims lack strong scientific support, study finds.

12 Oct 2026

Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia

Amphista Therapeutics Limited ('Amphista'), a leader in the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced dosing of the first patient in a Phase 1 trial for its lead candidate, AMX-883. Initiated following authorization from the U.S. Food and Drug Administration in June 2026, the BRAMLIE trial will investigate the safety, pharmacokinetics, and preliminary efficacy of AMX-883 monotherapy in participants with AML and high-risk MDS.

From Amphista Therapeutics 12 Oct 2026

Study reveals continued care delays among patients with young-onset breast cancer

In an analysis of data on adolescents and young adults with breast cancer, lower income and younger age were linked with delays in care.

12 Oct 2026

Cancer News and Research

Latest Cancer News and Research

Developing biomaterials for soft tissue reconstruction

Childhood leukemia treatment causes rapid, lasting challenges for patient families

Women with polyendocrine metabolic ovarian syndrome more likely to have Alzheimer's and dementia

Replacement chemical for harmful phthalates may restrict fetal growth

Single-cell analysis reveals how pancreatic cancer evades treatment

Undecimal Bio launches with $18 million oversubscribed seed financing to address ‘liver trap’ in siRNA therapeutic delivery

Study identifies Piezo channels as targets for orthodontic care

Long non-coding RNAs offer new pathways to overcome cancer treatment resistance

RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers

Review highlights EP4 receptor as target for inflammatory diseases

Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer

Targeting lipophagy could help treat metabolic and oxidative stress-related diseases

New review highlights expanding potential of therapeutic DNA vaccines

Buck Institute and Georgetown lead effort mapping harmful protein changes before disease begins

Oregon's licensed psilocybin centers prioritize safety but remain highly expensive

Magnetically guided millirobots deliver targeted drugs to beating hearts

Study maps psychological networks linked to suicidal ideation

Most online breast cancer diet advice lacks strong evidence

Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia

Study reveals continued care delays among patients with young-onset breast cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Newsletters you may be interested in